Piramal Pharma (NSE:PPLPHARMA) Dividends per Share : ₹0.00 (TTM As of Mar. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Piramal Pharma Dividends per Share?

Piramal Pharma's dividends per share for the three months ended in Mar. 2024 was ₹0.00. Its dividends per share for the trailing twelve months (TTM) ended in Mar. 2024 was ₹0.00. Its Dividend Payout Ratio for the three months ended in Mar. 2024 was 0.00. As of today, Piramal Pharma's Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

Piramal Pharma Dividends per Share Historical Data

The historical data trend for Piramal Pharma's Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Piramal Pharma Dividends per Share Chart

Piramal Pharma Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Dividends per Share

Piramal Pharma Quarterly Data
	Mar21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Dividends per Share	Get a 7-Day Free Trial							-	-	-	-	-

Competitive Comparison of Piramal Pharma's Dividends per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Piramal Pharma's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Piramal Pharma's Dividend Yield % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Piramal Pharma's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Piramal Pharma's Dividend Yield % falls into.

Piramal Pharma Dividends per Share Calculation

Dividends paid to per common share.

Piramal Pharma (NSE:PPLPHARMA) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Piramal Pharma's Dividend Payout Ratio for the quarter that ended in Mar. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Mar. 2024 )	/	EPS without NRI (Q: Mar. 2024 )
	=	0	/	0.941
	=	0.00

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Piramal Pharma Dividends per Share Related Terms

Thank you for viewing the detailed overview of Piramal Pharma's Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Piramal Pharma (NSE:PPLPHARMA) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Piramal Pharma Ltd (NSE:PPLPHARMA) » Definitions » Dividends per Share

Traded in Other Exchanges

543635:India

Address

Piramal Ananta, Agastya Corporate Park, Opposite Fire Brigade, Kamani Junction, LBS Marg, Kurla (West), Mumbai, MH, IND, 400070

Website

https://www.piramal.com

Piramal Pharma Ltd offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across 15 global facilities and a global distribution network in over 100 countries. It includes integrated contract development and manufacturing organization business, complex hospital generics business, and India consumer healthcare business, selling over-the-counter products in India.

Piramal Pharma (NSE:PPLPHARMA) Headlines

No Headlines